Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Pre-operative oestradiol levels - relation to survival in breast cancer.

Holmberg L, Nordén T, Lindgren A, Wide L, Degerman M, Adami HO.

Eur J Surg Oncol. 2001 Mar;27(2):152-6.

PMID:
11289750
2.

Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer.

Eskelinen M, Nordén T, Lindgren A, Wide L, Adami HO, Holmberg L.

Eur J Surg Oncol. 2004 Jun;30(5):495-500.

PMID:
15135476
3.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
4.

Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer.

Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD.

Eur J Cancer. 1994;30A(4):445-8.

PMID:
8018400
5.

Serum oestradiol in women with and without breast disease.

Bennett IC, McCaffrey JF, McCaffrey E, Wyatt B.

Br J Cancer. 1990 Jan;61(1):142-6. Erratum in: Br J Cancer 1990 Aug;62(2):336.

6.

A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.

Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T.

Cancer. 2001 May 15;91(10):1854-61.

PMID:
11346866
7.

Serum progesterone and prognosis in operable breast cancer.

Mohr PE, Wang DY, Gregory WM, Richards MA, Fentiman IS.

Br J Cancer. 1996 Jun;73(12):1552-5.

8.

NSAID use and survival after breast cancer diagnosis in post-menopausal women.

Blair CK, Sweeney C, Anderson KE, Folsom AR.

Breast Cancer Res Treat. 2007 Jan;101(2):191-7. Epub 2006 Jul 6.

PMID:
16823508
9.

Association of sex hormone status with the bone loss of renal transplant patients.

Cueto-Manzano AM, Freemont AJ, Adams JE, Mawer B, Gokal R, Hutchison AJ.

Nephrol Dial Transplant. 2001 Jun;16(6):1245-50.

PMID:
11390727
10.

Waist-to-hip ratio and breast cancer mortality.

Borugian MJ, Sheps SB, Kim-Sing C, Olivotto IA, Van Patten C, Dunn BP, Coldman AJ, Potter JD, Gallagher RP, Hislop TG.

Am J Epidemiol. 2003 Nov 15;158(10):963-8.

PMID:
14607804
11.

Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.

Demicheli R, Bonadonna G, Hrushesky WJ, Retsky MW, Valagussa P.

Breast Cancer Res. 2004;6(6):R689-96. Epub 2004 Oct 11.

12.

Parity in relation to survival following breast cancer.

Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J.

Eur J Surg Oncol. 2009 Jul;35(7):702-8. doi: 10.1016/j.ejso.2008.03.017. Epub 2008 May 19.

PMID:
18490128
13.

Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.

Reinier KS, Vacek PM, Geller BM.

Breast Cancer Res Treat. 2007 Jul;103(3):343-8. Epub 2006 Oct 25.

PMID:
17063272
14.

Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.

Krajcik RA, Borofsky ND, Massardo S, Orentreich N.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1566-73.

15.

Weight gain prior to diagnosis and survival from breast cancer.

Cleveland RJ, Eng SM, Abrahamson PE, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1803-11.

16.

Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?

Borugian MJ, Sheps SB, Kim-Sing C, Van Patten C, Potter JD, Dunn B, Gallagher RP, Hislop TG.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1163-72.

17.

Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study.

Würtz SØ, Møller S, Mouridsen H, Hertel PB, Friis E, Brünner N.

Mol Cell Proteomics. 2008 Feb;7(2):424-30. Epub 2007 Nov 12.

18.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
19.

Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.

Murillo-Ortiz B, Pérez-Luque E, Malacara JM, Daza-Benítez L, Hernández-González M, Benítez-Bribiesca L.

Pathol Oncol Res. 2008 Dec;14(4):435-42. doi: 10.1007/s12253-008-9088-y. Epub 2008 Aug 28.

PMID:
18752050
20.

c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.

Quaranta M, Daniele A, Coviello M, Savonarola A, Abbate I, Venneri MT, Paradiso A, Stea B, Zito A, Labriola A, Schittulli F.

Tumori. 2006 Jul-Aug;92(4):311-7.

PMID:
17036522

Supplemental Content

Support Center